| Name | Title | Contact Details |
|---|
Flex America is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Transforming lives and communities with innovative and collaborative therapy, training and research. Company Overview: The Houston Galveston Institute (HGI) is a non-profit organization thatoffers a unique method of collaborative counseling and post-modern therapy to individuals, families and communities of all socioeconomic backgrounds. We base our approach on the belief That the client is the expert on his or her life and Circumstances. Our job, as therapists, is not to dictate treatment, but to shape the process using the values, desires and needs of our clients. Through this collaboration, clients find new solutions and the strength to endure Challenges and Overcome Obstacles.
lifeIMAGE is an interoperable medical image sharing network that helps healthcare providers access their patients` imaging records, regardless of where exams are performed or stored. It has been adopted by more than 120 multi-site health systems across the country to improve care coordination for patient consultations, referrals and transfers. This enables providers to improve the quality and timeliness of care, expand referral business, and eliminate wasteful spending.
Adheris is a Burlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.